Abeona Therapeutics Inc (NAS:ABEO)
$ 6.21 0.17 (2.81%) Market Cap: 268.98 Mil Enterprise Value: 162.08 Mil PE Ratio: 0 PB Ratio: 3.53 GF Score: 52/100

Q1 2021 Abeona Therapeutics Inc Earnings Call Transcript

May 25, 2021 / 12:30PM GMT
Release Date Price: $37.25 (-3.87%)
Operator

Good day, ladies and gentlemen, and welcome to the Abeona First Quarter Earnings Call.

(Operator Instructions)

It is now my pleasure to turn the floor over to your host, Gregory Gin, Vice President of Investor Relations and Corporate Communications at Abeona. Please go ahead.

Gregory Gin
Abeona Therapeutics Inc. - VP of IR & Corporate Communications

Thank you, Holly. Good morning, everyone, and welcome, and thank you for joining us on our first quarter 2021 conference call. The press release announcing the first quarter results and recent operational progress is available on our website at www.abeonatherapeutics.com. On the call today with prepared remarks are Michael Amoroso, Chief Executive Officer of Abeona; and Ed Carr, Chief Accounting Officer.

After the prepared remarks, we will host the Q&A session, where we will be joined by Dr. Juan Ruiz, Vice President at Abeona, who heads up clinical development for our MPS program; and Dr. Brian Kevany, a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot